Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Biofil Chemicals & Pharmaceuticals Ltd Fundamentals

Market Cap
₹ 112.04 Cr
P/E Ratio (TTM)
167.95
P/B Ratio
6.34
Debt to Equity
0.03
ROE
1.12
EPS (TTM)
0.41
Dividend Yield
0.00 %
Book Value
10.86

Click here to know more about Fundamentals

Biofil Chemicals & Pharmaceuticals Ltd Financials

Biofil Chemicals & Pharmaceuticals Ltd Financials

Biofil Chemicals & Pharmaceuticals Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 46.82 % 46.82 % 46.82 % 46.82 %
Retail 38.03 % 37.67 % 37.97 % 38.09 %
Others 15.12 % 15.51 % 15.21 % 15.09 %
FII 0.03 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

46.82%

Retail

38.03%

Others

15.12%

FII

0.03%

Mutual Funds

0.00%

Promoters

46.82%

Retail

37.67%

Others

15.51%

FII

0.00%

Mutual Funds

0.00%

Promoters

46.82%

Retail

37.97%

Others

15.21%

FII

0.00%

Mutual Funds

0.00%

Promoters

46.82%

Retail

38.09%

Others

15.09%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹68.65

PIVOT

resistance-arrow
Resistance
First Resistance₹70.300
Second Resistance₹71.150
Third Resistance₹72.800
support-arrow
Support
First Support₹67.800
Second Support₹66.150
Third Support₹65.300

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day31,31125,15858.02
Week52,80720,29013.49
1 Month52,80746,42713.49
6 Months18,281,1068,573,61259.42

About Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products. Later on, the Company was converted into a Public Limited Company on 7 May '92. The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. It runs the business via two unit viz Pharmaceutical Division & Chemicals Division. In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore. BCPL's new unit was set up at Pithampur in Madhya Pradesh at a project costing Rs 39.75 cr. The Company entered into business partnership with HLL Lifecare Limited (Formerly Hindustan Latex Ltd) an undertaking of Government of India. As per the agreed terms it provided manufacturing facility to HLL Lifecare Limited for manufacturing of Iron and Folic Acid Tablets (IFA) and other Pharmaceuticals products as required by HLL. Presently, the Company is flourishing business activates at Pithampur, in Madhya Pradesh. Now Company is not only dealing in the pharmaceutical product but has diversified its business activity in producing plastic products required for packing of pharmaceutical product and other plastic products.

Managing Director

1985

Founded

Ramesh Shah

NSE Symbol

BIOFILCHEM

Biofil Chemicals & Pharmaceuticals Ltd Management

NameDesignation
Ramesh ShahChairman & Managing Director
Romil ShahNon Executive Director
Shaila JainIndependent Director
Satish BeoharIndependent Director
Ashok Kumar RamawatIndependent Director
Ketan ShahWhole-time Director
Shweta VermaCompany Sec. & Compli. Officer
Gayatri PadiyarIndependent Director

Biofil Chemicals & Pharmaceuticals Ltd News

Biofil Chemicals & Pharmaceuticals standalone net profit declines 10.00% in the December 2023 quarter
Sales rise 237.58% to Rs 5.03 crore
Biofil Chemicals & Pharmaceuticals to declare Quarterly Result
On 6 February 2024
Biofil Chemicals & Pharmaceuticals standalone net profit rises 140.00% in the September 2023 quarter
Sales rise 562.98% to Rs 17.37 crore
Biofil Chemicals & Pharmaceuticals to hold board meeting
On 9 November 2023
Biofil Chemicals & Pharmaceuticals AGM scheduled
On 27 September 2023
Biofil Chemicals & Pharmaceuticals to announce Quarterly Result
On 14 August 2023
Biofil Chemicals & Pharmaceuticals reports standalone net profit of Rs 0.21 crore in the March 2023 quarter
Sales rise 725.45% to Rs 13.62 crore
Biofil Chemicals & Pharmaceuticals to declare Quarterly Result
On 30 May 2023
Biofil Chemicals & Pharmaceuticals standalone net profit declines 70.59% in the December 2022 quarter
Sales decline 8.59% to Rs 1.49 crore
Biofil Chemicals & Pharmaceuticals to declare Quarterly Result
On 14 February 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
Sun Pharmaceuticals Industries Ltd₹ 367434.16 Cr
₹ 1,531.40
(-0.32 %)
89.20
Cipla Ltd₹ 112958.59 Cr
₹ 1,399.05
(-1.55 %)
30.42
Zydus Lifesciences Ltd₹ 105795.44 Cr
₹ 1,051.40
(4.20 %)
39.38
Divis Laboratories Ltd₹ 103818.12 Cr
₹ 3,910.75
(-0.52 %)
76.14
Dr Reddys Laboratories Ltd₹ 96747.09 Cr
₹ 5,799.55
(-0.87 %)
22.28

Biofil Chemicals & Pharmaceuticals Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Biofil Chemicals & Pharmaceuticals Ltd shares in BlinkX

Biofil Chemicals & Pharmaceuticals Ltd's P/E ratio is 167.95 times as of May 17, 2024 at 04:14 PM.

Biofil Chemicals & Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 6.34, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Biofil Chemicals & Pharmaceuticals Ltd's market is 112 Cr as on May 17, 2024 at 04:14 PM.

The current financial records of Biofil Chemicals & Pharmaceuticals Ltd show a 1.12% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

According to Biofil Chemicals & Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of Crores, which includes current and non-current assets such as inventory, cash, properties, and equipment.

As of the Mar 2024 quarter, the promoter shareholding in Biofil Chemicals & Pharmaceuticals Ltd stands at 46.82%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 0.00% to 0.03%.